BrainStorm Cell Therapeutics Inc (BCLI): Great critique of recent SA article on G...

Send PM Follow Ignore

Re: None

Wednesday, 10/22/2014 11:39:27 AM

Wednesday, October 22, 2014 11:39:27 AM

Great critique of recent SA article on Genervon's trial results for ALS, which applies to CUR and BCLI.

http://smithonstocks.com/weakness-in-neuralstem-caused-by-seeking-alpha-article-presents-a-buying-opportunity-cur-2-69-buy/

Keep Last Read

Replies (1) Next 10 Prev Next

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/09/2025 07:20:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2025 09:03:10 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/03/2025 08:31:22 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/25/2025 08:39:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2025 08:31:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 08:30:51 PM
Micro-Cap Biotech Spikes After Revealing Strong ALS Survival Outcomes • AllPennyStocks.com • 06/16/2025 05:27:00 PM
Micro Cap Bid Up Aggressively On FDA Clearance Announcement • AllPennyStocks.com • 05/19/2025 01:50:00 PM
Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/06/2025 08:30:33 PM

Go Ad-Free